arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

download Export Data

iHuman Inc.

$1.36 0.00 (0.00%) at close

7 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Neutral

auto_awesome

Analytical Summary

iHuman Inc. shows mixed fundamentals. Consider comparing against peers in the Industrials sector before making investment decisions.

Market Cap $349.5M

Dividend Yield —

Revenue Growth -8.7% ↗

Op. Margin 8.3% ↗

ROIC 6.3% ↘

FCF / Share $0.03 ↘

Trailing P/E 27.2x

Price / Book 2.5x

FCF Yield 2.1%

Debt / Equity —

info Valuation on last close. End-of-day price, Jul 28, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$115.40M

↓ -8.7% —

Net Income Profit after all expenses

$13.64M

↑ +1.0% —

Operating Margin Operating profit as % of sales

8.3%

↑ +6.1% 52th

FCF / Share Free cash flow per share

$0.03

↓ -6.7% —

Health Breakdown

Profitability ↑

Returns

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗
Revenue Growth YoY (%)	-8.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-273%)	-11.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-338%)	0.4% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-93%)	-3.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-172%)	81.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1537%)	—	—
EPS Growth YoY (%)	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	-50.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	66.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—
Net Income Growth YoY (%)	1.0% Caution ↓ Caution Declining Year-over-year change in net income	-47.0% Weak ↓ Weak Declining Year-over-year change in net income	60.0% Excellent Excellent Year-over-year change in net income	N/M	-1.3% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-6.7% Weak ↓ Weak Declining Year-over-year change in free cash flow	-66.7% Weak ↓ Weak Declining Year-over-year change in free cash flow	-10.4% Weak Weak Year-over-year change in free cash flow	355.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—
Revenue CAGR 3Y (%)	-6.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-5.2% Weak Weak Compound annual revenue growth over 3 years	20.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	7.2% Fair Fair Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	-5.9% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗
Operating Margin (%) (%)	8.3% Caution ↓ Caution Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-31%)	7.8% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-35%)	15.7% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+31%)	11.3% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-6%)	-5.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-148%)	-8.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-170%)	—
Effective Tax Rate (%) (%)	6.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	10.9% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	10.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	17.3% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.3% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	11.8% Fair ↓ Fair Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+48%)	10.7% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+34%)	17.8% Good ↑ Good Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+122%)	11.1% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+39%)	-3.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-149%)	-7.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-188%)	—
FCF Margin (%) (%)	6.4% Caution ↓ Caution Declining Free cash flow as a percentage of revenue Optimal: > 10%	6.3% Caution ↓ Caution Declining Free cash flow as a percentage of revenue Optimal: > 10%	16.9% Good ↓ Good Declining Free cash flow as a percentage of revenue Optimal: > 10%	19.1% Good ↓ Good Declining Free cash flow as a percentage of revenue Optimal: > 10%	4.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	41.9% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.54x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.72x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-1.03x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-5.95x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗
Return on Invested Capital (%)	6.3% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	6.7% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	14.9% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	12.0% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-7.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	4.9% Caution ↓ Caution Declining Operating profit relative to total assets Optimal: > 10%	5.1% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	11.0% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	8.4% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	-4.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-4.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	9.6% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-36%)	10.3% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-32%)	18.9% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+26%)	14.3% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	-6.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	-5.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-139%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗
Net Debt (USD)	$-164.61M	$-153.89M	$-170.96M	$-152.24M	$-134.22M	$-132.06M	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗
Revenue per Share (USD)	$0.45	$0.48	$0.54	$0.54	$0.56	—	—
Basic EPS, GAAP (USD)	$0.05	$0.05	$0.10	$0.06	$-0.02	—	—
Free Cash Flow per Share (USD)	$0.03	$0.03	$0.09	$0.10	$0.02	—	—
Book Value per Share (USD)	$0.55	$0.50	$0.51	$0.42	$0.36	—	—
Tangible Book Value per Share (USD)	$0.55	$0.50	$0.51	$0.42	$0.36	—	—
Basic Weighted Avg Shares (shares)	256.98M	262.00M	264.05M	266.54M	266.63M	—	181.43M

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗
Working Capital (USD)	$133.62M	$121.69M	$125.59M	$100.44M	$83.53M	$95.36M	—
Total Equity (USD)	$142.31M	$131.63M	$134.90M	$111.56M	$95.47M	$98.49M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗
Sales/Revenue/Turnover (USD)	$115.40M	$126.34M	$143.40M	$142.89M	$148.25M	$81.52M	—
Depreciation Expense (USD)	$1.11M	$1.87M	$1.65M	$1.57M	$1.01M	$431.00K	—
Net Income, GAAP (USD)	$13.64M	$13.51M	$25.48M	$15.92M	$-5.81M	$-5.74M	—
Operating Cash Flow (USD)	$7.34M	$8.02M	$24.24M	$27.32M	$6.00M	$34.18M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 7 quarters

iHuman Inc.

Analytical Summary

7-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare IH with peers